Abstract
A method is presented for electrochemical determination of the breast cancer biomarker HER2. A glassy carbon electrode (GCE) was modified with densely packed gold nanoparticles placed on a composite consisting of electrochemically reduced graphene oxide and single walled carbon nanotubes (ErGO-SWCNTs). An aptamer directed against HER2 was then immobilized ono the GCE. The modified GCE was characterized by cyclic voltammetry, differential pulse voltammetry and electrochemical impedance spectroscopy. The immobilized aptamer selectively recognizes HER2 on the electrode interface, and this leads to an increased charge transfer resistance (Rct) of the electrode when using ferri/ferro-cyanide as the electrochemical probe. The method has a low limit of detection (50 fg·mL−1) and a wide analytical range (0.1 pg·mL−1 to 1 ng·mL−1). The assay is highly reproducible and specific. Clinical application was demonstrated by analysis of the HER2 levels in serum samples, and sera of breast cancer patients were successfully discriminated from sera of healthy persons.
Similar content being viewed by others
References
Hurvitz S, McCann K (2019) HER2-positive breast cancer. Elsevier, St. Louis
Hung M-C, Matin A, Zhang Y, Xing X, Sorgi F, Huang L, Yu D (1995) HER-2/neu-targeting gene therapy-a review. Gene 159:65–71
Perez EA, Cortés J, Gonzalez-Angulo AM, Bartlett JMS (2014) HER2 testing: current status and future directions. Cancer Treat Rev 40:276–284
Xu B, Shen J, Guo W, Zhao W, Zhuang Y, Wang L (2019) Impact of the 2018 ASCO/CAP HER2 guidelines update for HER2 testing by FISH in breast cancer. Pathol Res Pract 215:251–255
Hirschmann A, Lamb TA, Marchal G, Padilla M, Diebold J (2012) Simultaneous analysis of HER2 gene and protein on a single slide facilitates HER2 testing of breast and gastric carcinomas. Am J Clin Pathol 138:837–844
Lim S-J, Cantillep A, Carpenter PM (2013) Validation and workflow optimization of human epidermal growth factor receptor 2 testing using INFORM HER2 dual-color in situ hybridization. Hum Pathol 44:2590–2596
Ding J, Zhou Y, Li JJ, Jiang LP, He ZW, Zhu JJ (2015) Screening of HER2 overexpressed breast cancer subtype in vivo by the validation of high-performance long-term, and noninvasive fluorescence tracer. Anal Chem 87:12290–12297
Kao KJ, Tai CH, Chang WH, Yeh TS, Chen TC, Lee GB (2015) A fluorescence in situ hybridization (FISH) microfluidic platform for detection of HER2 amplification in cancer cells. Biosens Bioelectron 69:272–279
Zhang M, Gao G, Ding Y, Deng C, Xiang J, Wu H (2019) A fluorescent aptasensor for the femtomolar detection of epidermal growth factor receptor-2 based on the proximity of G-rich sequences to Ag nanoclusters. Talanta 199:238–243
Shen C, Zeng K, Luo J, Li X, Yang M, Rasooly A (2017) Self-assembled DNA generated electric current biosensor for HER2 analysis. Anal Chem 89:10264–10269
Qureshi A, Gurbuz Y, Niazi JH (2015) Label-free capacitance based aptasensor platform for the detection of HER2/ErbB2 cancer biomarker in serum. Sensors Actuators B 220:1145–1151
Shen C, Liu S, Li X, Zhao D, Yang M (2018) Immunoelectrochemical detection of the human epidermal growth factor receptor 2 (HER2) via gold nanoparticle-based rolling circle amplification. Microchim Acta 185:547–553
Chai Y, Li X, Yang M (2019) Aptamer based determination of the cancer biomarker HER2 by using phosphate-functionalized MnO2 nanosheets as the electrochemical probe. Microchim Acta 186:316–322
Marques RCB, Viswanathan S, Nouws HPA, Delerue-Matos C, González-García MB (2014) Electrochemical immunosensor for the analysis of the breast cancer biomarker HER2 ECD. Talanta 129:594–599
Bahadır EB, Sezgintürk MK (2015) Applications of electrochemical immunosensors for early clinical diagnostics. Talanta 132:162–174
Pacheco JG, Rebelo P, Freitas M, Nouws HPA, Delerue-Matos C (2018) Breast cancer biomarker (HER2-ECD) detection using a molecularly imprinted electrochemical sensor. Sensors Actuators B 273:1008–1014
Sharma S, Zapatero-Rodríguez J, Saxena R, O’Kennedy R, Srivastava S (2018) Ultrasensitive direct impedimetric immunosensor for detection of serum HER2. Biosens Bioelectron 106:78–85
Marques RCB, Costa-Rama E, Viswanathan S, Nouws HPA, Costa-García A, Delerue-Matos C, González-García MB (2018) Voltammetric immunosensor for the simultaneous analysis of the breast cancer biomarkers CA 15-3 and HER2-ECD. Sensors Actuators B 255:918–925
Heydari-Bafrooei E, Askari S (2017) Ultrasensitive aptasensing of lysozyme by exploiting the synergistic effect of gold nanoparticle-modified reduced graphene oxide and MWCNTs in a chitosan matrix. Microchim Acta 184:3405–3413
Ensafi AA, Jamei HR, Heydari-Bafrooei E, Rezaei B (2016) Electrochemical study of quinone redox cycling: a novel application of DNA-based biosensors for monitoring biochemical reactions. Bioelectrochemistry 111:15–22
Yang S, You M, Zhang F, Wang Q, He P (2018) A sensitive electrochemical aptasensing platform based on exonuclease recycling amplification and host-guest recognition for detection of breast cancer biomarker HER2. Sensors Actuators B 258:796–802
Yang Y, Yang X, Yang Y, Yuan Q (2018) Aptamer-functionalized carbon nanomaterials electrochemical sensors for detecting cancer relevant biomolecules. Carbon 129:380–395
Gupta S, Murthy CN, Prabha CR (2018) Recent advances in carbon nanotube based electrochemical biosensors. Int J Biol Macromol 108:687–703
Arkan E, Saber R, Karimi Z, Shamsipur M (2015) A novel antibody–antigen based impedimetric immunosensor for low level detection of HER2 in serum samples of breast cancer patients via modification of a gold nanoparticles decorated multiwall carbon nanotube-ionic liquid electrode. Anal Chim Acta 874:66–74
Tabasi A, Noorbakhsh A, Sharifi E (2017) Reduced graphene oxide-chitosan-aptamer interface as new platform for ultrasensitive detection of human epidermal growth factor receptor 2. Biosens Bioelectron 95:117–123
Yan H, Tang X, Zhu X, Zeng Y, Lua X, Yin Z, Lu Y, Yang Y, Li L (2018) Sandwich-type electrochemical immunosensor for highly sensitive determination of cardiac troponin I using carboxyl-terminated ionic liquid and helical carbon nanotube composite as platform and ferrocenecarboxylic acid as signal label. Sensors Actuators B 277:234–240
Scheller FW, Zhang X, Yarman A, Wollenberger U, Gyurcsányi RE (2019) Molecularly imprinted polymer-based electrochemical sensors for biopolymers. Curr Opin Electrochem 14:53–59
Labib M, Green B, Mohamadi RM, Mepham A, Ahmed SU, Mahmoudian L, Chang I-H, Sargent EH, Kelley SO (2016) Aptamer- and antisense-mediated two-dimensional isolation of specific cancer cell subpopulations. J Am Chem Soc 1388:2476–2479
Zhang Z, Chen HH, Xing CY, Guo MY, Xu FG, Wang XD, Gruber HJ, Zhang BL, Tang JL (2011) Sodium citrate: a universal reducing agent for reduction / decoration of graphene oxide with au nanoparticles. Nano Res 4:599–611
Sharma H, Kaushik V, Avasthi DK, Shukla AK, Vankar VD (2012) Au-nanoparticles-decorated MWCNTs demonstrating enhanced fluorescence and Raman spectroscopy. AIP Conf Proc 1451:58–60
Acknowledgements
The authors gratefully acknowledge the support of this work by the Research Council of Vali-e-Asr University of Rafsanjan (VRU), Iran.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
The author(s) declare that they have no competing interests.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Electronic supplementary material
ESM 1
(DOC 5311 kb)
Rights and permissions
About this article
Cite this article
Rostamabadi, P.F., Heydari-Bafrooei, E. Impedimetric aptasensing of the breast cancer biomarker HER2 using a glassy carbon electrode modified with gold nanoparticles in a composite consisting of electrochemically reduced graphene oxide and single-walled carbon nanotubes. Microchim Acta 186, 495 (2019). https://doi.org/10.1007/s00604-019-3619-y
Received:
Accepted:
Published:
DOI: https://doi.org/10.1007/s00604-019-3619-y